美股A股
StockGist

Integra LifeSciences Holdings Corporation

IARTNASDAQ · Healthcare · Medical - Devices
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity recon…
$14.40+0.35%
报价 2026-11-13
市值
$1.12B
EV
$2.9B
PE (TTM)
88.0x
预期 PE (FY2026)
6.2x
52 周区间距高点 -27.5%
$8.90$19.85

筛选结果

pipeline · 2026-11-13
Filter✗ 高增长✗ Cheap✗ GARP
does not hit growth, cheap, or GARP pool

爆发潜力

2026-11-13
未命中✗ 收入线✗ EPS 线
财年收入倍数EPSPE
FY+22027-121.0x2.52 → 2.37(0.9x)6.1
FY+32028-121.0x2.52 → 2.47(1.0x)5.8

毛利率 52% · TTM 收入 $1657M · 基数 EPS 2.52(调整后)

研究结论

还没有研究记录。先生成 L2 基本面报告(约 1–3 分钟),结论会显示在这里。

去生成基本面报告 →

历史股价

加载中…

事件

0 条 · 随区间与图例筛选

该区间内无事件。

同行对比

FMP 同行列表 · 2026-05-16
公司市值今日预期营收增速毛利率PEEV/EBITDAP/FCF池
IARTIntegra LifeSciences Holdings Corporation$1.12B+0.3%+0.8%51%88.0x12.4x16.0x
MRVIMaravai LifeSciences Holdings, Inc.$2.14B-1.8%+16.0%34.6%–––
SEPNSepterna, Inc.$2.03B+1.8%+149.0%99.4%––16.4x
FTREFortrea Holdings Inc.$1.91B+0.7%-1.9%17.1%–34.8x12.5x
BFLYButterfly Network, Inc.$1.63B-8.8%+36.0%73%–––高增长
TNDMTandem Diabetes Care, Inc.$1.4B+14.6%+7.6%56.5%–––
INMDInMode Ltd.$763.6M+0.6%–77.8%10.7x5.3x–Cheap
BCAXBicara Therapeutics Inc. Common Stock$665.2M-0.9%–0%–––
PACBPacific Biosciences of California, Inc.$612M-0.5%-0.6%36%–––
同行中位数––+11.8%46.3%10.7x20.1x14.4x

研究全文

L2 基本面 memo

尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。

财务报表

Metric
2026-09-30
Q3 2026
2026-06-30
Q2 2026
2026-03-31
Q1 2026
2025-12-31
Q4 2025
2025-09-30
Q3 2025
2025-06-30
Q2 2025
2025-03-31
Q1 2025
2024-12-31
Q4 2024
Revenue$411.2M$418.8M$391.9M$434.9M$402.1M$415.6M$382.7M$442.6M
Gross Margin51%52.5%57.2%49.5%56.2%50.4%50.8%56.3%
Operating Margin4.6%4.6%10.2%127.9%10%-123.4%-4%8%
Net Income$14.9M$4.5M$-4.6M$-1.7M$-5.4M$-484.1M$-25.3M$19.4M
Diluted EPS0.190.06-0.06-0.02-0.07-6.33-0.330.25
Operating Cash Flow$96M$22.8M$9.8M$11.8M$40.9M$8.9M$-11.3M$50.7M

研究材料